Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04411 |
| Species: | Homo sapiens |
| Position : | chr17:69541883-69542989 |
| Year: | 2017 |
| Title: | Altered SOX9 genital tubercle enhancer region in hypospadias. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 27989796 |
| Cell Source: | TM4 |
| Experiment Type: | Enhancer activity assay; In vivo functional validation |
| Low Throughput Method: | Luciferase reporter assay; Reporter assay; Transgenic/LacZ assay; Histology/immunostaining |
| Target gene : | SOX9 |
| TF name : | SOX9 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| SOX9 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| SOX9 | TGF_beta_Receptor | netpath | 220 |
| SOX9 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| SOX9 | Hs_Spinal_Cord_Injury_WP2431_87678 | wikipathways | 21 |